BioSpace News Archive

Transplantation Market New Growth Challenges during Covid-19, Industry Type, Application, Business Opportunities, Future Forecast 2030

The global transplantation market size is expected to reach USD 32.94 Billion in 2030 and register a revenue CAGR of 11.5% over the forecast period, according to the latest report by Reports and Data.

July 5, 2022
·
5 min read
Head and Neck Cancer Market: Increase in Patient Population to Propel Market

Wilmington, Delaware, United States, Transparency Market Research Inc.: Transparency Market Research has published a new report titled, “Head and Neck Cancer Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

July 5, 2022
·
7 min read
Dementia Associated with Alzimer’s Disease Market: Growing Geriatric Population and Unmet Clinical Needs in Alzheimer’s Patients are Projected to Boost the Market

Wilmington, Delaware, United States, Transparency Market Research Inc.: Transparency Market Research has published a new report titled, “Dementia Associated with Alzheimer’s Disease Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

July 5, 2022
·
8 min read
Sick Sinus Syndrome Treatment Market: Increase in Prevalence of Heart Diseases to Drive the Market

Wilmington, Delaware, United States, Transparency Market Research Inc.: Sick sinus syndrome is a group disorder including three heart rhythm problems : sinus bradycardia, tachycardias, and bradycardia-tachycardia.

July 5, 2022
·
7 min read
Drug Development

ANeuroTech receives positive feedback from the FDA for its pivotal Phase IIIb development programme for ANT-01 as an adjunctive anti-depression drug for Major Depressive Disorder

ANeuroTech announces that following a successful pre-IND meeting, the US Food and Drug Administration has given positive feedback on its pivotal Phase IIIb development programme of ANT-01 as an adjunctive anti-depression drug for Major Depressive Disorder.

July 5, 2022
·
4 min read
Business

Aurigene Discovery Technologies Limited Announces Drug Discovery, Development and Commercialization Partnership with EQRx

The collaboration combines Aurigene’s small molecule drug discovery platform and EQRx’s pioneering business model to accelerate the development of drug candidates in the areas of oncology and immune-inflammatory diseases and improve global access to innovative medicines.

July 5, 2022
·
2 min read
Deals

Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement

Combined Company Will Operate as Syros Pharmaceuticals and Continue to Advance Syros’ Ongoing Clinical Programs.

July 5, 2022
·
17 min read
Drug Development

Ayala Pharmaceuticals Announces Interim Data from Part A of the Phase 2/3 RINGSIDE Trial of AL102 in Desmoid Tumors

Ayala Pharmaceuticals, Inc. today announced positive interim results from Part A of the ongoing RINGSIDE Pivotal Phase 2/3 clinical trial evaluating AL102 in desmoid tumors. AL102 is a potent, selective, oral gamma-secretase inhibitor (GSI).

July 5, 2022
·
11 min read
Business

Inspire Medical Systems, Inc. to Report Second Quarter 2022 Financial Results on August 2, 2022

Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the second quarter 2022 after the close of trading on Tuesday, August 2.

July 5, 2022
·
1 min read
Business

Eloxx Pharmaceuticals Announces Changes to Board of Directors

Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a leader in ribosomal RNA-targeted genetic therapies for rare diseases, today announced the appointment of Lindsay Androski, JD, MBA to its board of directors and as a member of the Board’s Audit Committee and Compensation Committee.

July 5, 2022
·
4 min read